Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Vaccine Production01:23

Vaccine Production

57
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
57
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K
Vaccinations01:51

Vaccinations

53.7K
Overview
53.7K
Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Humoral Immune Responses01:36

Humoral Immune Responses

86.1K
Overview
86.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting.

EBioMedicine·2025
Same author

Controlled Human Infection Models To Accelerate Vaccine Development.

Clinical microbiology reviews·2022
Same author

WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20-22 April 2021.

Emerging microbes & infections·2022
Same author

The TB vaccine development pathway - An innovative approach to accelerating global TB vaccine development.

Tuberculosis (Edinburgh, Scotland)·2020
Same author

Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations.

Vaccine·2019
Same author

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.

The Lancet. Respiratory medicine·2019

Related Experiment Video

Updated: Mar 29, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.4K

Human challenge trials in vaccine development: Strasbourg, September 29 - October 1, 2014.

Rebecca L Sheets1, Bernard Fritzell1, M Teresa Aguado de Ros1

  • 1International Alliance for Biological Standardization, Lyon, France.

Biologicals : Journal of the International Association of Biological Standardization
|November 28, 2015
PubMed
Summary

Human Challenge Trials (HCT) are valuable for vaccine development, aiding in target exploration and efficacy evaluation. These trials should be continued and encouraged when scientifically justified, balancing risks and benefits for public health.

Keywords:
Clinical efficacyDevelopmentHuman challenge trialsSerologic correlatesVaccines

More Related Videos

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.5K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.4K

Related Experiment Videos

Last Updated: Mar 29, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.4K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.5K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.4K

Area of Science:

  • Vaccinology and Infectious Disease Research
  • Clinical Trial Design and Ethics

Background:

  • An international workshop convened to discuss the critical role of Human Challenge Trials (HCT) in advancing vaccine development.
  • HCT are recognized as essential tools for exploring vaccine targets, identifying immune correlates of protection, and evaluating clinical efficacy.

Purpose of the Study:

  • To review the scientific presentations and panel discussions from the workshop on HCT.
  • To highlight key questions, challenges, and propose recommendations for the future development of international guidance on HCT.

Main Methods:

  • The workshop featured scientific presentations and panel discussions involving experts in vaccine development.
  • Discussions focused on the scientific justification, ethical considerations, and practical implementation of HCT.
  • Key outcomes included the formulation of twenty recommendations for international guidance.

Main Results:

  • HCT have proven to be useful and, in some cases, the only feasible method for advancing investigational products.
  • Numerous HCT have been successfully conducted safely and ethically, significantly benefiting vaccine development and public health.
  • A strong scientific justification is paramount, balancing investigational objectives against the inherent risks of administering infectious organisms.

Conclusions:

  • Human Challenge Trials (HCT) should be continued and encouraged when scientifically appropriate, given their proven utility.
  • Future international guidance on HCT should address scientific justification, risk-benefit assessment, and ethical conduct.
  • The workshop underscored the importance of HCT in accelerating vaccine development and improving global public health outcomes.